Bioventures Investors — 2020 Investments
1 investments dated 2020 · listed companies and verified rows first · show all
Biofeedback DesignOct 2020SEC filingmedium confidence
HealthtechBoston, US
Sharyn Chabot(Executive Officer)Gene Zylkuski(Executive Officer, Director)Jonathan Paull Gertler(Director)Mark Goldberg(Director)
Board seatJonathan Gertler· per SEC Form D · $3.2M raise · filed Nov 2020
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.